Prof. Dr. med. habil. AC Feller Etablierung neuer immunhis

7. Literaturverzeichnis
1) Archuleta TD, Armitage JO: Advances in Follicular Lymhoma. Semin Oncol
31, 66-71 (2004)
2) Armitage JO, Weisenburger DD (for the Non-Hodgkin`s Lymphoma
Classification Project): New Approach to Classifying Non-Hodgkin`s
Lymphomas: Clinical Features of the Major Histologic Subtypes. J Clin Oncol
16, 2780-2795 (1998)
3) Aviles A, Neri N, Cuadra I, Alvarado I, Fernandez R, Calva A, Huerta-Guzman
J: Lack of Prognostic Factors in Follicular Lymphoma. Leuk Lymphoma 44,
143-147 (2003)
4) Behrens TW, Kearns GM, Rivard JJ, Bernstein HD, Yewdell JW, Staudt LM:
Carboxyl-terminal Targeting and Novel Post-translational Processing of JAW1,
a Lymphoid Protein of the Endoplasmic Reticulum. J Biol Chem 271, 23528-
23534 (1996)
5) Biagi JJ, Seymour JF: Insights into the molecular pathogenesis of follicular
lymphoma arising from analysis of geographic variation. Blood 99, 4265-4275
(2002)
6) Bilalovic N, Blystad AK, Goulouh R, Nesland JM, Selak I, Trinh D, Torlakovic
E: Expression of bcl-6 and CD10 Protein is Associated With Longer Overall
Survival and Time to Treatment Failure in Follicular Lymphoma. Am J Clin
Pathol 121, 34-42 (2004)
7) Björk E, Ek S, Landgren O, Jerkeman M, Ehinger M, Björkholm M, Borrebaeck
CAK, Porwit-MacDonald A, Nordenskjöld M: High expression of cyclin B1
predicts a favorable outcome in patients with follicular lymphoma. Blood 105,
2908-15 (2005)
8) Bordeleau L, Berinstein NL: Molecular Diagnostics in Follicular Lymphoma: A
Review. Semin Oncol 27, 42-52 (2000)
9) Brechot C: Oncogenic activation of cyclin A. Curr Opin Genet Dev 3, 11-18
(1993)
10) Chang KC, Huang X, Medeiros LJ, Jones D: Germinal centre-like versus
undifferentiated stromal immunophenotypes in follicular lymphomas. J Pathol
201, 404-412 (2003)
53